Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease-Reference-Cited by-同舟云学术

Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease

Published:2018-08-10 Issue:6 Volume:27 Page:1023-1032
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Abengózar-Vela Antonio¹^ORCID,Schaumburg Chris S.²,Stern Michael E.²,Calonge Margarita¹³^ORCID,Enríquez-de-Salamanca Amalia¹³^ORCID,González-García María Jesús¹³^ORCID

Affiliation:

1. IOBA, University of Valladolid, Valladolid, Spain

2. Biological Sciences, Inflammation Research Program, Allergan, Inc., Irvine, CA, USA

3. Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Valladolid, Spain

Funder

Universidad de Valladolid

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2018.1497664

Reference49 articles.

1. Prevalence of and Risk Factors for Dry Eye Syndrome

2. Prevalence of dry eye syndrome among US women

3. TFOS DEWS II pathophysiology report

4. Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease

5. Dry Eye as a Mucosal Autoimmune Disease

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular basis of the immunomodulatory effects of natural products: A comprehensive review;Phytomedicine;2024-12

2. Resveratrol and lipoic acid: A promising combination for treating dry eye disease;Journal of Drug Delivery Science and Technology;2024-09

3. Quercetin inhibits hypertonicity-induced inflammatory injury in human corneal epithelial cells via the PTEN/PI3K/AKT pathway;Tissue and Cell;2024-08

4. Biochanin A: Disrupting the inflammatory vicious cycle for dry eye disease;European Journal of Pharmacology;2024-08

5. Network Pharmacology Study of Qingxuan Runmu Decoction in the Treatment of Dry Eye Disease;Advances in Clinical Medicine;2024